{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T18:27:15Z","timestamp":1789064835885,"version":"build-2803163510"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,2,20]],"date-time":"2018-02-20T00:00:00Z","timestamp":1519084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,2,20]],"date-time":"2018-02-20T00:00:00Z","timestamp":1519084800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Angiotensin-converting enzyme inhibitors (ACEIs) can improve the fibrotic processes in many internal organs. Recent studies have shown a relationship between ACEI with cutaneous scar formation, although it has not been confirmed, and the underlying mechanism is unclear. In this study, we cultured mouse NIH 3T3 fibroblasts with different concentrations of ACEI. We measured cell proliferation with a Cell Counting Kit-8 and collagen expression with a Sirius Red Collagen Detection Kit. Flow cytometry and western blotting were used to detect transforming growth factor \u03b21 (TGF-\u03b21) signaling. We also confirmed the potential antifibrotic activity of ACEI in a rat scar model. ACEI reduced fibroblast proliferation, suppressed collagen and TGF-\u03b21 expression, and downregulated the phosphorylation of SMAD2\/3 and TAK1, both <jats:italic>in vitro<\/jats:italic> and <jats:italic>in vivo<\/jats:italic>. A microscopic examination showed that rat scars treated with ramipril or losartan were not only narrower than in the controls, but also displayed enhanced re-epithelialization and neovascularization, and the formation of organized granulation tissue. These data indicate that ACEI inhibits scar formation by suppressing both TGF-\u03b21\/SMAD2\/3 and TGF-\u03b21\/TAK1 pathways, and may have clinical utility in the future.<\/jats:p>","DOI":"10.1038\/s41598-018-21600-w","type":"journal-article","created":{"date-parts":[[2018,2,14]],"date-time":"2018-02-14T10:50:16Z","timestamp":1518605416000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":58,"title":["Angiotensin-converting enzyme inhibitor reduces scar formation by inhibiting both canonical and noncanonical TGF-\u03b21 pathways"],"prefix":"10.1038","volume":"8","author":[{"given":"Qing-Qing","family":"Fang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Feng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan-Yi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-Li","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bang-Hui","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Hong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cai-Yun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Qiang","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,20]]},"reference":[{"key":"21600_CR1","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/jid.2013.328","volume":"134","author":"Y Qi","year":"2014","unstructured":"Qi, Y. et al. TSG-6 released from intradermally injected mesenchymal stem cells accelerates wound healing and reduces tissue fibrosis in murine full-thickness skin wounds. J. Invest. Dermatol. 134, 526\u2013537, https:\/\/doi.org\/10.1038\/jid.2013.328 (2014).","journal-title":"J. Invest. Dermatol."},{"key":"21600_CR2","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1016\/j.bbadis.2009.06.004","volume":"1792","author":"D Pohlers","year":"2009","unstructured":"Pohlers, D. et al. TGF-beta and fibrosis in different organs - molecular pathway imprints. Biochimica et biophysica acta 1792, 746\u2013756, https:\/\/doi.org\/10.1016\/j.bbadis.2009.06.004 (2009).","journal-title":"Biochimica et biophysica acta"},{"key":"21600_CR3","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1038\/jid.2012.443","volume":"133","author":"HF Yuan","year":"2013","unstructured":"Yuan, H. F. et al. A dual AP-1 and SMAD decoy ODN suppresses tissue fibrosis and scarring in mice. The Journal of investigative dermatology 133, 1080\u20131087, https:\/\/doi.org\/10.1038\/jid.2012.443 (2013).","journal-title":"The Journal of investigative dermatology"},{"key":"21600_CR4","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1001\/archfacial.2012.223","volume":"14","author":"JR Thomas","year":"2012","unstructured":"Thomas, J. R. & Somenek, M. Scar revision review. Archives of Facial Plastic Surgery 14, 162\u2013174 (2012).","journal-title":"Archives of Facial Plastic Surgery"},{"key":"21600_CR5","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1111\/bjd.13954","volume":"173","author":"P Martin","year":"2015","unstructured":"Martin, P. & Nunan, R. Cellular and molecular mechanisms of repair in acute and chronic wound healing. British Journal of Dermatology 173, 370\u2013378 (2015).","journal-title":"British Journal of Dermatology"},{"key":"21600_CR6","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1111\/ijd.12436","volume":"53","author":"LY Kerwin","year":"2014","unstructured":"Kerwin, L. Y., El Tal, A. K., Stiff, M. A. & Fakhouri, T. M. Scar prevention and remodeling: a review of the medical, surgical, topical and light treatment approaches. Int. J. Dermatol. 53, 922\u2013936, https:\/\/doi.org\/10.1111\/ijd.12436 (2014).","journal-title":"Int. J. Dermatol."},{"issue":"Suppl 10","key":"21600_CR7","doi-asserted-by":"publisher","first-page":"S265","DOI":"10.1097\/DSS.0000000000000496","volume":"41","author":"B Balaraman","year":"2015","unstructured":"Balaraman, B., Geddes, E. R. & Friedman, P. M. Best Reconstructive Techniques: Improving the Final Scar. Dermatol Surg 41(Suppl 10), S265\u2013275, https:\/\/doi.org\/10.1097\/dss.0000000000000496 (2015).","journal-title":"Dermatol Surg"},{"key":"21600_CR8","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1111\/j.1365-4632.2010.04678.x","volume":"50","author":"MR Namazi","year":"2011","unstructured":"Namazi, M. R., Fallahzadeh, M. K. & Schwartz, R. A. Strategies for prevention of scars: what can we learn from fetal skin? Int. J. Dermatol. 50, 85\u201393, https:\/\/doi.org\/10.1111\/j.1365-4632.2010.04678.x (2011).","journal-title":"Int. J. Dermatol."},{"key":"21600_CR9","doi-asserted-by":"publisher","first-page":"3498","DOI":"10.1172\/JCI68127","volume":"123","author":"A Nystrom","year":"2013","unstructured":"Nystrom, A. et al. Collagen VII plays a dual role in wound healing. J. Clin. Invest. 123, 3498\u20133509, https:\/\/doi.org\/10.1172\/jci68127 (2013).","journal-title":"J. Clin. Invest."},{"key":"21600_CR10","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1111\/bjd.13954","volume":"173","author":"P Martin","year":"2015","unstructured":"Martin, P. & Nunan, R. Cellular and molecular mechanisms of repair in acute and chronic wound healing. Br. J. Dermatol. 173, 370\u2013378, https:\/\/doi.org\/10.1111\/bjd.13954 (2015).","journal-title":"Br. J. Dermatol."},{"issue":"Suppl 10","key":"21600_CR11","doi-asserted-by":"publisher","first-page":"S265","DOI":"10.1097\/DSS.0000000000000496","volume":"41","author":"B Balaraman","year":"2015","unstructured":"Balaraman, B., Geddes, E. R. & Friedman, P. M. Best Reconstructive Techniques: Improving the Final Scar. Dermatologic surgery: official publication for American Society for Dermatologic Surgery [et al.] 41(Suppl 10), S265\u2013275, https:\/\/doi.org\/10.1097\/dss.0000000000000496 (2015).","journal-title":"Dermatologic surgery: official publication for American Society for Dermatologic Surgery [et al.]"},{"key":"21600_CR12","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1007\/s00059-003-2524-6","volume":"28","author":"CG Brilla","year":"2003","unstructured":"Brilla, C. G., Rupp, H. & Maisch, B. Effects of ACE inhibition versus non-ACE inhibitor antihypertensive treatment on myocardial fibrosis in patients with arterial hypertension. Retrospective analysis of 120 patients with left ventricular endomyocardial biopsies. Herz 28, 744\u2013753, https:\/\/doi.org\/10.1007\/s00059-003-2524-6 (2003).","journal-title":"Herz"},{"key":"21600_CR13","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.cca.2005.12.012","volume":"367","author":"A Mohammadi-Karakani","year":"2006","unstructured":"Mohammadi-Karakani, A., Ghazi-Khansari, M. & Sotoudeh, M. Lisinopril ameliorates paraquat-induced lung fibrosis. Clinica chimica acta; international journal of clinical chemistry 367, 170\u2013174, https:\/\/doi.org\/10.1016\/j.cca.2005.12.012 (2006).","journal-title":"Clinica chimica acta; international journal of clinical chemistry"},{"key":"21600_CR14","doi-asserted-by":"publisher","first-page":"e202","DOI":"10.1097\/MJT.0b013e3181df8df5","volume":"18","author":"A Ghulam","year":"2011","unstructured":"Ghulam, A., Silveira, M. G. & Lindor, K. D. Hepatic fibrosis and the renin-angiotensin system. American Journal of Therapeutics 18, e202\u2013208 (2011).","journal-title":"American Journal of Therapeutics"},{"key":"21600_CR15","first-page":"15","volume":"68","author":"I Kolesnyk","year":"2010","unstructured":"Kolesnyk, I., Struijk, D. G., Dekker, F. W. & Krediet, R. T. Effects of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in patients with chronic kidney disease. The Netherlands journal of medicine 68, 15\u201323 (2010).","journal-title":"The Netherlands journal of medicine"},{"key":"21600_CR16","first-page":"60","volume":"8","author":"S Iannello","year":"2006","unstructured":"Iannello, S., Milazzo, P., Bordonaro, F. & Belfiore, F. Low-dose enalapril in the treatment of surgical cutaneous hypertrophic scar and keloid\u2013two case reports and literature review. Medgenmed Medscape General Medicine 8, 60 (2006).","journal-title":"Medgenmed Medscape General Medicine"},{"key":"21600_CR17","doi-asserted-by":"publisher","first-page":"361e","DOI":"10.1097\/PRS.0b013e31829acf0a","volume":"132","author":"U Hakan","year":"2013","unstructured":"Hakan, U., Ozan, B., R\u00fcmeysa, H. L., Pergin, A. & Aycan U. Ur., K. I. L. Angiotensin-converting enzyme inhibitor enalapril reduces formation of hypertrophic scars in a rabbit ear wounding model. Plastic & Reconstructive Surgery 132, 361e\u2013371e (2013).","journal-title":"Plastic & Reconstructive Surgery"},{"key":"21600_CR18","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s00441-011-1179-5","volume":"347","author":"H Ikushima","year":"2012","unstructured":"Ikushima, H. & Miyazono, K. TGF-beta signal transduction spreading to a wider field: a broad variety of mechanisms for context-dependent effects of TGF-beta. Cell Tissue Res. 347, 37\u201349, https:\/\/doi.org\/10.1007\/s00441-011-1179-5 (2012).","journal-title":"Cell Tissue Res."},{"key":"21600_CR19","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.bbadis.2008.01.006","volume":"1782","author":"KJ Gordon","year":"2008","unstructured":"Gordon, K. J. & Blobe, G. C. Role of transforming growth factor-beta superfamily signaling pathways in human disease. Biochimica et biophysica acta 1782, 197\u2013228, https:\/\/doi.org\/10.1016\/j.bbadis.2008.01.006 (2008).","journal-title":"Biochimica et biophysica acta"},{"key":"21600_CR20","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1073\/pnas.0909781107","volume":"107","author":"S Inokuchi","year":"2010","unstructured":"Inokuchi, S. et al. Disruption of TAK1 in hepatocytes causes hepatic injury, inflammation, fibrosis, and carcinogenesis. Proceedings of the National Academy of Sciences 107, 844\u2013849 (2010).","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"21600_CR21","doi-asserted-by":"publisher","first-page":"163","DOI":"10.3109\/08977194.2011.614236","volume":"29","author":"S Itoh","year":"2011","unstructured":"Itoh, S. & Itoh, F. Inhibitory machinery for the TGF-beta family signaling pathway. Growth Factors 29, 163\u2013173, https:\/\/doi.org\/10.3109\/08977194.2011.614236 (2011).","journal-title":"Growth Factors"},{"key":"21600_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-01702-7","volume":"7","author":"H Shima","year":"2017","unstructured":"Shima, H. et al. A novel indole compound MA-35 attenuates renal fibrosis by inhibiting both TNF-alpha and TGF-beta1pathways. Scientific reports 7, 1884, https:\/\/doi.org\/10.1038\/s41598-017-01702-7 (2017).","journal-title":"Scientific reports"},{"key":"21600_CR23","doi-asserted-by":"publisher","first-page":"196","DOI":"10.3109\/08977194.2011.595714","volume":"29","author":"A Biernacka, M Dobaczewski, NG Frangogiannis(INSERT AUTHOR NAME AFTER CHECK IN GOOGLE)","year":"2011","unstructured":"Biernacka, A., Dobaczewski, M. & Frangogianni, N. G. TGF-\u03b2 signaling in fibrosis. Growth Factors 29, 196\u2013202 (2011).","journal-title":"Growth Factors"},{"key":"21600_CR24","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.semnephrol.2012.04.003","volume":"32","author":"ME Choi","year":"2012","unstructured":"Choi, M. E., Ding, Y. & Kim, S. I. TGF-\u03b2 Signaling via TAK1 Pathway: Role in Kidney Fibrosis. Seminars in Nephrology 32, 244\u2013252 (2012).","journal-title":"Seminars in Nephrology"},{"key":"21600_CR25","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/S0092-8674(03)00432-X","volume":"113","author":"Y Shi","year":"2003","unstructured":"Shi, Y. & Massague, J. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 113, 685\u2013700 (2003).","journal-title":"Cell"},{"key":"21600_CR26","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1111\/1523-1747.ep12343658","volume":"106","author":"A Ghahary","year":"1996","unstructured":"Ghahary, A. et al. Collagenase production is lower in post-burn hypertrophic scar fibroblasts than in normal fibroblasts and is reduced by insulin-like growth factor-1. Journal of Investigative Dermatology 106, 476\u2013481 (1996).","journal-title":"Journal of Investigative Dermatology"},{"key":"21600_CR27","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1023\/A:1006985329240","volume":"19","author":"FM Heemskerk","year":"1999","unstructured":"Heemskerk, F. M., Zorad, S., Xu, N., Gutkind, S. J. & Saavedra, J. M. Characterization of AT2 receptor expression in NIH 3T3 fibroblasts. Cell. Mol. Neurobiol. 19, 277\u2013288 (1999).","journal-title":"Cell. Mol. Neurobiol."},{"key":"21600_CR28","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1097\/BOR.0b013e32830e48e8","volume":"20","author":"J Varga","year":"2008","unstructured":"Varga, J. & Pasche, B. Antitransforming growth factor-beta therapy in fibrosis: recent progress and implications for systemic sclerosis. Curr. Opin. Rheumatol. 20, 720\u2013728, https:\/\/doi.org\/10.1097\/BOR.0b013e32830e48e8 (2008).","journal-title":"Curr. Opin. Rheumatol."},{"key":"21600_CR29","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/nrrheum.2009.26","volume":"5","author":"J Varga","year":"2009","unstructured":"Varga, J. & Pasche, B. Transforming growth factor beta as a therapeutic target in systemic sclerosis. Nature reviews. Rheumatology 5, 200\u2013206, https:\/\/doi.org\/10.1038\/nrrheum.2009.26 (2009).","journal-title":"Nature reviews. Rheumatology"},{"key":"21600_CR30","doi-asserted-by":"publisher","first-page":"140","DOI":"10.3109\/08977194.2011.595411","volume":"29","author":"LJ Hawinkels","year":"2011","unstructured":"Hawinkels, L. J. & Ten Dijke, P. Exploring anti-TGF-beta therapies in cancer and fibrosis. Growth Factors 29, 140\u2013152, https:\/\/doi.org\/10.3109\/08977194.2011.595411 (2011).","journal-title":"Growth Factors"},{"key":"21600_CR31","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/BF00229743","volume":"165","author":"IM Dixon","year":"1996","unstructured":"Dixon, I. M., Ju, H., Jassal, D. S. & Peterson, D. J. Effect of ramipril and losartan on collagen expression in right and left heart after myocardial infarction. Mol. Cell. Biochem. 165, 31\u201345 (1996).","journal-title":"Mol. Cell. Biochem."},{"key":"21600_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/srep33677","volume":"6","author":"Q Wei","year":"2016","unstructured":"Wei, Q. et al. Ramipril attenuates left ventricular remodeling by regulating the expression of activin A-follistatin in a rat model of heart failure. Scientific reports 6, 33677, https:\/\/doi.org\/10.1038\/srep33677 (2016).","journal-title":"Scientific reports"},{"key":"21600_CR33","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/nrc1877","volume":"6","author":"R Kalluri","year":"2006","unstructured":"Kalluri, R. & Zeisberg, M. Fibroblasts in cancer. Nat Review Cancer 6, 392\u2013401, https:\/\/doi.org\/10.1038\/nrc1877 (2006).","journal-title":"Nat Review Cancer"},{"key":"21600_CR34","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1007\/s00109-014-1190-x","volume":"92","author":"B Eckes","year":"2014","unstructured":"Eckes, B., Moinzadeh, P., Sengle, G., Hunzelmann, N. & Krieg, T. Molecular and cellular basis of scleroderma. Journal of Molecular Medicine 92, 913\u2013924 (2014).","journal-title":"Journal of Molecular Medicine"},{"key":"21600_CR35","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1038\/jid.2015.86","volume":"135","author":"M Schmidt","year":"2015","unstructured":"Schmidt, M. et al. Controlling the Balance of Fibroblast Proliferation and Differentiation: Impact of Thy-1. Journal of Investigative Dermatology 135, 1893\u20131902 (2015).","journal-title":"Journal of Investigative Dermatology"},{"key":"21600_CR36","first-page":"56","volume":"146","author":"A Desmouliere","year":"1995","unstructured":"Desmouliere, A., Redard, M., Darby, I. & Gabbiani, G. Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar. The American journal of pathology 146, 56\u201366 (1995).","journal-title":"The American journal of pathology"},{"key":"21600_CR37","doi-asserted-by":"publisher","first-page":"113","DOI":"10.2119\/molmed.2009.00153","volume":"17","author":"GG Gauglitz","year":"2011","unstructured":"Gauglitz, G. G., Korting, H. C., Pavicic, T., Ruzicka, T. & Jeschke, M. G. Hypertrophic scarring and keloids: pathomechanisms and current and emerging treatment strategies. Mol. Med. 17, 113\u2013125, https:\/\/doi.org\/10.2119\/molmed.2009.00153 (2011).","journal-title":"Mol. Med."},{"key":"21600_CR38","doi-asserted-by":"publisher","first-page":"5788","DOI":"10.1073\/pnas.84.16.5788","volume":"84","author":"SM Wahl","year":"1987","unstructured":"Wahl, S. M. et al. Transforming growth factor type beta induces monocyte chemotaxis and growth factor production. Proceedings of the National Academy of Sciences of the United States of America 84, 5788\u20135792 (1987).","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"21600_CR39","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/cr.2008.326","volume":"19","author":"MJ Goumans","year":"2009","unstructured":"Goumans, M. J., Liu, Z. & ten Dijke, P. TGF-beta signaling in vascular biology and dysfunction. Cell Res. 19, 116\u2013127, https:\/\/doi.org\/10.1038\/cr.2008.326 (2009).","journal-title":"Cell Res."},{"key":"21600_CR40","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.tcb.2010.06.006","volume":"20","author":"E Pardali","year":"2010","unstructured":"Pardali, E., Goumans, M. J. & ten Dijke, P. Signaling by members of the TGF-beta family in vascular morphogenesis and disease. Trends Cell Biol. 20, 556\u2013567, https:\/\/doi.org\/10.1016\/j.tcb.2010.06.006 (2010).","journal-title":"Trends Cell Biol."},{"issue":"Suppl 1","key":"21600_CR41","doi-asserted-by":"publisher","first-page":"S54","DOI":"10.1111\/j.1524-475X.2007.00226.x","volume":"15","author":"KR Cutroneo","year":"2007","unstructured":"Cutroneo, K. R. TGF-beta-induced fibrosis and SMAD signaling: oligo decoys as natural therapeutics for inhibition of tissue fibrosis and scarring. Wound Repair Regen. 15(Suppl 1), S54\u201360, https:\/\/doi.org\/10.1111\/j.1524-475X.2007.00226.x (2007).","journal-title":"Wound Repair Regen."},{"key":"21600_CR42","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.cellsig.2012.10.003","volume":"25","author":"R Samarakoon","year":"2013","unstructured":"Samarakoon, R., Overstreet, J. M. & Higgins, P. J. TGF-beta signaling in tissue fibrosis: redox controls, target genes and therapeutic opportunities. Cell. Signal. 25, 264\u2013268, https:\/\/doi.org\/10.1016\/j.cellsig.2012.10.003 (2013).","journal-title":"Cell. Signal."},{"key":"21600_CR43","doi-asserted-by":"crossref","first-page":"4337","DOI":"10.1016\/S0021-9258(17)35666-1","volume":"261","author":"RA Ignotz","year":"1986","unstructured":"Ignotz, R. A. & Massague, J. Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. The Journal of biological chemistry 261, 4337\u20134345 (1986).","journal-title":"The Journal of biological chemistry"},{"key":"21600_CR44","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s00403-014-1532-0","volume":"307","author":"E Karimizadeh","year":"2015","unstructured":"Karimizadeh, E. et al. Attenuation of fibrosis with selective inhibition of c-Abl by siRNA in systemic sclerosis dermal fibroblasts. Arch Dermatol Res 307, 135\u2013142, https:\/\/doi.org\/10.1007\/s00403-014-1532-0 (2015).","journal-title":"Arch Dermatol Res"},{"key":"21600_CR45","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s00395-014-0421-1","volume":"109","author":"D Fraccarollo","year":"2014","unstructured":"Fraccarollo, D. et al. Soluble guanylyl cyclase activation improves progressive cardiac remodeling and failure after myocardial infarction. Cardioprotection over ACE inhibition. Basic Res. Cardiol. 109, 421, https:\/\/doi.org\/10.1007\/s00395-014-0421-1 (2014).","journal-title":"Basic Res. Cardiol."},{"key":"21600_CR46","doi-asserted-by":"publisher","unstructured":"Li, E. C., Heran, B. S. & Wright, J. M. Angiotensin converting enzyme (ACE) inhibitors versus angiotensin receptor blockers for primary hypertension. The Cochrane database of systematic reviews, CD009096, https:\/\/doi.org\/10.1002\/14651858.CD009096.pub2 (2014).","DOI":"10.1002\/14651858.CD009096.pub2"},{"key":"21600_CR47","doi-asserted-by":"publisher","unstructured":"Abadir, P. et al. Topical Reformulation of Valsartan for Treatment of Chronic Diabetic Wounds. J. Invest. Dermatol., https:\/\/doi.org\/10.1016\/j.jid.2017.09.030 (2017).","DOI":"10.1016\/j.jid.2017.09.030"},{"key":"21600_CR48","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1111\/j.0906-6705.2004.0139.x","volume":"13","author":"UM Steckelings","year":"2004","unstructured":"Steckelings, U. M. et al. Human skin: source of and target organ for angiotensin II. Experimental dermatology 13, 148\u2013154, https:\/\/doi.org\/10.1111\/j.0906-6705.2004.0139.x (2004).","journal-title":"Experimental dermatology"},{"key":"21600_CR49","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1111\/j.1365-2133.2005.06806.x","volume":"153","author":"UM Steckelings","year":"2005","unstructured":"Steckelings, U. M., Henz, B. M., Wiehstutz, S., Unger, T. & Artuc, M. Differential expression of angiotensin receptors in human cutaneous wound healing. Br. J. Dermatol. 153, 887\u2013893, https:\/\/doi.org\/10.1111\/j.1365-2133.2005.06806.x (2005).","journal-title":"Br. J. Dermatol."},{"key":"21600_CR50","doi-asserted-by":"publisher","first-page":"13209","DOI":"10.1074\/jbc.M509771200","volume":"281","author":"Y Yahata","year":"2006","unstructured":"Yahata, Y. et al. A novel function of angiotensin II in skin wound healing. Induction of fibroblast and keratinocyte migration by angiotensin II via heparin-binding epidermal growth factor (EGF)-like growth factor-mediated EGF receptor transactivation. The Journal of biological chemistry 281, 13209\u201313216, https:\/\/doi.org\/10.1074\/jbc.M509771200 (2006).","journal-title":"The Journal of biological chemistry"},{"key":"21600_CR51","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1177\/1938640010376994","volume":"3","author":"CL Scimeca","year":"2010","unstructured":"Scimeca, C. L. et al. An update on pharmacological interventions for diabetic foot ulcers. Foot & ankle specialist 3, 285\u2013302, https:\/\/doi.org\/10.1177\/1938640010376994 (2010).","journal-title":"Foot & ankle specialist"},{"key":"21600_CR52","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1016\/S0140-6736(05)67700-8","volume":"366","author":"V Falanga","year":"2005","unstructured":"Falanga, V. Wound healing and its impairment in the diabetic foot. Lancet 366, 1736\u20131743, https:\/\/doi.org\/10.1016\/s0140-6736(05)67700-8 (2005).","journal-title":"Lancet"},{"key":"21600_CR53","doi-asserted-by":"publisher","first-page":"e2","DOI":"10.1017\/S1462399409000945","volume":"11","author":"L Pradhan","year":"2009","unstructured":"Pradhan, L., Nabzdyk, C., Andersen, N. D., LoGerfo, F. W. & Veves, A. Inflammation and neuropeptides: the connection in diabetic wound healing. Expert reviews in molecular medicine 11, e2, https:\/\/doi.org\/10.1017\/s1462399409000945 (2009).","journal-title":"Expert reviews in molecular medicine"},{"key":"21600_CR54","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.18632\/aging.100868","volume":"7","author":"M Faghih","year":"2015","unstructured":"Faghih, M. et al. Knockout of Angiotensin AT2 receptors accelerates healing but impairs quality. Aging (Albany NY) 7, 1185\u20131197, https:\/\/doi.org\/10.18632\/aging.100868 (2015).","journal-title":"Aging (Albany NY)"},{"key":"21600_CR55","doi-asserted-by":"publisher","first-page":"785247","DOI":"10.1155\/2012\/785247","volume":"2012","author":"E Zandifar","year":"2012","unstructured":"Zandifar, E., Sohrabi Beheshti, S., Zandifar, A. & Haghjooy Javanmard, S. The effect of captopril on impaired wound healing in experimental diabetes. International journal of endocrinology 2012, 785247, https:\/\/doi.org\/10.1155\/2012\/785247 (2012).","journal-title":"International journal of endocrinology"},{"key":"21600_CR56","doi-asserted-by":"publisher","first-page":"170","DOI":"10.3389\/fphys.2015.00170","volume":"6","author":"M Kamber","year":"2015","unstructured":"Kamber, M. et al. Angiotensin II inhibitor facilitates epidermal wound regeneration in diabetic mice. Front Physiol 6, 170, https:\/\/doi.org\/10.3389\/fphys.2015.00170 (2015).","journal-title":"Front Physiol"},{"key":"21600_CR57","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1111\/j.1600-0625.2010.01186.x","volume":"20","author":"WQ Tan","year":"2011","unstructured":"Tan, W. Q., Gao, Z. J., Xu, J. H. & Yao, H. P. Inhibiting scar formation in vitro and in vivo by adenovirus-mediated mutant Smad4: a preliminary report. Experimental dermatology 20, 119\u2013124, https:\/\/doi.org\/10.1111\/j.1600-0625.2010.01186.x (2011).","journal-title":"Experimental dermatology"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-21600-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-21600-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-21600-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T02:35:33Z","timestamp":1671590133000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-21600-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,20]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["21600"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-21600-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,20]]},"assertion":[{"value":"12 June 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"3332"}}